ZhuZhou QianJin Pharmaceutical Co.,Ltd (SHA:600479)
China flag China · Delayed Price · Currency is CNY
10.21
-0.06 (-0.58%)
May 20, 2026, 2:45 PM CST

SHA:600479 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
664.85780.151,3441,9981,240632.88
Short-Term Investments
----18251.94
Trading Asset Securities
1.551.944.76-491.74736.84
Cash & Short-Term Investments
666.41782.081,3491,9981,9141,422
Cash Growth
-28.65%-42.03%-32.47%4.40%34.61%-5.74%
Accounts Receivable
1,020819.27823.34912.54847.17830.93
Other Receivables
96.417.7515.7528.2627.8331.23
Receivables
1,117837.02839.09940.8875862.16
Inventory
487490.35485.94534.14598.99547.78
Prepaid Expenses
--6.180.240.733.44
Other Current Assets
63.1354.1548.4841.4125.0782.22
Total Current Assets
2,3332,1642,7293,5143,5132,917
Property, Plant & Equipment
617.35606.08561.31589.93547.02630.19
Long-Term Investments
1,7921,812953.32247.61187.59190.77
Goodwill
14.0714.0714.0714.0714.0714.07
Other Intangible Assets
226.5231.77208.22212.21195.11201.9
Long-Term Deferred Tax Assets
25.1822.9416.9722.6719.294.12
Long-Term Deferred Charges
102.690.4367.4471.7371.4176.98
Other Long-Term Assets
22.7722.686.034.1886.6424.93
Total Assets
5,1344,9644,5564,6774,6354,060
Accounts Payable
842.14702.98565.64647.49780.92511.67
Accrued Expenses
79.89197.54376.14402.93376.04267.41
Short-Term Debt
20.259.7111.956.6958.1367.09
Current Portion of Long-Term Debt
15.0513.32753.53
Current Portion of Leases
--13.7816.5617.8418.55
Current Income Taxes Payable
31.6632.653.6337.2831.2923.89
Current Unearned Revenue
76.7298.2495.27123.61131.2199.59
Other Current Liabilities
513.39386.67259.43252.27298.3237.22
Total Current Liabilities
1,5791,4911,3331,5421,6971,228
Long-Term Debt
---71215.5
Long-Term Leases
26.9928.5125.9631.4632.7644.79
Long-Term Unearned Revenue
59.262.1133.6638.0444.4451.27
Pension & Post-Retirement Benefits
--1.91.91.91.9
Long-Term Deferred Tax Liabilities
26.323.8317.6524.7224.0613.22
Other Long-Term Liabilities
7.957.955.195.195.195.19
Total Liabilities
1,6991,6141,4171,6501,8181,360
Common Stock
492.21492.21424428.92429.81418.51
Additional Paid-In Capital
941.59941.57603.25631.18635.44585.49
Retained Earnings
1,6681,5931,4501,3631,1921,146
Treasury Stock
---16.56-35.02-41.81-
Comprehensive Income & Other
1.761.761.581.591.40.75
Total Common Equity
3,1033,0282,4622,3902,2172,150
Minority Interest
331.04321.86676.87637.08600.07549.55
Shareholders' Equity
3,4343,3503,1393,0272,8172,700
Total Liabilities & Equity
5,1344,9644,5564,6774,6354,060
Total Debt
62.23101.5458.64116.71124.24148.93
Net Cash (Debt)
604.18680.551,2911,8811,7891,273
Net Cash Growth
-30.99%-47.27%-31.39%5.13%40.60%-5.93%
Net Cash Per Share
1.351.583.124.454.183.04
Filing Date Shares Outstanding
492.15492.21424428.92428.12418.51
Total Common Shares Outstanding
492.15492.21424428.92428.12418.51
Working Capital
754.35672.491,3961,9731,8161,689
Book Value Per Share
6.316.155.815.575.185.14
Tangible Book Value
2,8632,7822,2402,1632,0081,934
Tangible Book Value Per Share
5.825.655.285.044.694.62
Buildings
--799.74780.42765.95650.15
Machinery
--491.41485.55395.8436.31
Construction In Progress
--13.356.125.7894.34
Source: S&P Global Market Intelligence. Standard template. Financial Sources.